¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Interferon Beta-1b Injection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endermic injection
    ÇÇ(ºÎ)³»ÁÖ»ç
  • epidural injection
    °æÁú¸·¹Ù±ùÁÖ»ç, °æ¸·¿ÜÁÖ»ç
  • epifascial injection
    ±Ù¸·¿ÜÁÖ»ç, ±Ù¸·¹Ù±ùÁÖ»ç
  • hypodermic injection
    ÇÇÇÏÁÖ»ç, ÇǺιØÁÖ»ç
  • intravascular injection
    Ç÷°ü³»ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³»ÁÖ»ç
  • injection
    1. ÁÖ»ç 2. ÃæÇ÷
  • injection molding method
    »çÃ⼺Çü¹ý
  • intra-arterial injection
    µ¿¸Æ³»ÁÖ»ç
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç, Àü¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç, ±ÙÀ°ÁÖ»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypodermic injection
    ÇǺιØÁÖ»ç, ÇÇÇÏÁÖ»ç
  • injection
    ÁÖ»ç, ÃæÇ÷
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý
  • injection molding method
    »çÃ⼺Çü¹ý
  • intra-arterial injection
    µ¿¸Æ³»ÁÖ»ç
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    (¢¡intradermal injection) ÇǺγ»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç
  • intraperitoneal injection
    º¹¸·¾ÈÁÖ»ç, º¹°­³»ÁÖ»ç
  • intrapleural injection
    °¡½¿¸·°ø°£ÁÖ»ç, È丷°­³»ÁÖ»ç
  • intravascular injection
    Ç÷°ü³»ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³»ÁÖ»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interferon-¥â (INF-¥â)
    º£Å¸ÀÎÅÍÆä·Ð
  • interferon-¥ã (INF-¥ã)
    °¨¸¶ÀÎÅÍÆä·Ð
  • arterial injection
    µ¿¸ÆÁÖ»ç.
  • bolus injection
    ÀϽÃÁÖ»ç
  • bolus injection
    ÀϽÃÁÖ»ç.
  • booster injection
    ºÎ¿ì½ºÅÍÁÖ»ç(¡­ñ¼ÞÒ), Ãß°¡Á¢Á¾(õÚÊ¥ïÈðú).
  • cavernosal injection
    ÇØ¸éü ÁÖÀÔ(ÁÖ»ç)
  • ciliary injection
    ¸ð¾çÃæÇ÷(¡­õöúì).
  • circumcorneal injection
    °¢¸·ÁÖÀ§ÃæÇ÷, ¸ð¾çÃæÇ÷
  • collagen injection
    Äݶó°Õ ÁÖÀÔ(ÁÖ»ç)
  • conjunctival injection
    °á¸·ÃæÇ÷(¡­õöúì).
  • dental injection needle
    Ä¡°ú¿ë ÁÖ»çħ(¡­ñ¼ÞÒöÜ).
  • endermic injection
    Çdz»ÁÖ»ç(¡­ñ¼ÞÒ).
  • endodermic injection
    Çdz»ÁÖ»ç(¡­ñ¼ÞÒ).
  • epifascial injection
    ±Ù¸·¿Ü ÁÖ»ç(ÐÉØ¯èâ ñ¼ÞÒ), ±Ù¸·»ó ÁÖ»ç(¡­ñ¼ÞÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IV Intra-Venous(ly) injection; Á¤¸ÆÀ¸·Î, Á¤¸ÆÁÖ»ç
S.C. Sub Cutis; Sub-Cutaneous(ly) injection; ÇÇÇÏ·Î, ÇÇÇÏÁÖ»ç
BWFI bacteriostatic water for injection
CID cellular immunodeficiency; charge injection device; chick infective dose; combined immunodeficiency ...
ESI elastase-specific inhibitor; enzyme substrate inhibitor; epidural steroid injection
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IDU Injection drug use
IDU Injection drug users
125I Injection of
ICSI Intra Cytoplasmic Sperm Injection
ICI Intracavernous injection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • intraarticular injection
    °üÀý³» ÁÖ»ç
  • intracutaneous injection
    Çdz» ÁÖ»ç
    Çdz»¿¡ ¾à¹°À» ÁÖÀÔÇÏ´Â ¹æ¹ýÀ¸·Î Áúº´ÀÇ Áø´Ü ¹× ¿¹¹æÀ» À§ÇØ Èí¼ö¸¦ ´À¸®°Ô ÇÏ°í ¾àÈ¿¸¦ °¡´ÉÇÑÇÑ Áö¼Ó½Ã۱⸦ ¹Ù¶ó´Â °æ¿ì ¹× ´Ù¸¥ ÁÖ»ç¹ýÀ¸·Î¼­´Â ºÎÀû´çÇÑ ¾àÁ¦ÀÇ °æ¿ì µî¿¡ ÇàÇØÁø´Ù. ¸¹Àº °æ¿ì ¹ÝÀÀÀÌ ´«À¸·Î º¸Àδٴ Ư¡ÀÌ ÀÖ´Ù.
  • intramuscular injection
    ±Ù³» ÁÖ»ç, ±ÙÀ°³» ÁÖ»ç, ±ÙÀ° ÁÖ»ç
    ¾àÁ¦¸¦ ±ÙÀ°¿¡ ÁÖ»çÇÏ´Â °Í. ÇÇÇÏ Áֻ翡 ºñÇØ¼­ Èí¼ö°¡ ºü¸£°í 2-5mlÀ» Àû¿ëÇÒ ¼ö ÀÖ´Ù. ÀÚ±Ø, ÅëÁõÀÌ °­ÇÑ °ÍÀ̳ª À¯¼ºÀÇ ¾àÁ¦ µî ¶Ç Èí¼ö°¡ ³ª»Û °ÍÀÌ ±ÙÀ° Áֻ翡¼­ Àû¿ëµÈ´Ù.
  • intraosseous, interseptal, intrapulpal injection
    °ñ³», Á߰ݰ£, Ä¡¼ö³» ÁÖ»ç
  • intrapulpal injection
    Ä¡¼ö ³» ÁÖ»ç
  • intravascular injection
    Ç÷°ü³» ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³» ÁÖ»ç
  • mercurophylline injection
    ¸ÓÅ¥·ÎÇʸ° ÁÖ»ç¾×
  • paraperiosteal injection
    °ñ¸· ÁÖÀ§ ÁÖ»ç
  • paravertebral injection
    ôÃß ÁÖÀ§ ÁÖ»ç
  • post-injection trismus
    ÁÖ»ç ÈÄ ¾Æ°ü±ä±Þ
  • pre/post gadolinium injection
    °¡µ¹¸®´½ ÁÖÀÔÀü/ÈÄ
  • retrogasserian injection of glycerol

    retrogasserian neurotomy (°¡¼¼¸£ ½Å°æÀý Èı٠Àý´Ü¼ú

  • subcutaneous injection
    ÇÇÇÏ ¸¶Ãë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
type II interferon <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
type I interferon <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
fibroblast interferon <cytokine> One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity.
Synonym: fibroblast interferon.
Pharmacological action: adjuvants, immunologic, antineoplastic agent, antiviral agents.
Chemical name: Interferon-alphaB (human leukocyte protein moiety reduced)
(12 Dec 1998)
leukocyte interferon <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products.
It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia.
A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents.
See: interferon-alpha 2a, interferon-alpha 2b
Synonym: leukocyte interferon.
Pharmacological action: antineoplastic agent, antiviral agent.
(20 Sep 2002)
adrenal cortex injection An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease.
(05 Mar 2000)
bolus injection <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion).
(18 Nov 1997)
regular insulin injection A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma.
Synonym: regular insulin injection.
(05 Mar 2000)
Ringer's injection A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher.
(05 Mar 2000)
water for injection Water purified by distillation for the preparation of products for parenteral use.
(05 Mar 2000)
collagen injection Correction of superficial soft tissue deformities, acne scars, or age-related skin changes by injection (implantation) of collagen; bovine collagen preparations are commonly used. Prior intradermal testing is necessary to exclude hypersensitivity.
(05 Mar 2000)
selective injection Injection of contrast medium following selective catheterization of a branch artery or vein for angiography.
(05 Mar 2000)
sensitizing injection An injection that sensitises a person so that subsequent exposure to the antigen (allergen) evokes an allergic response.
(05 Mar 2000)
hypodermic injection The administration of a remedy in liquid form by injection into the subcutaneous tissues.
Synonym: hypodermic.
(05 Mar 2000)
neutral beam injection <radiobiology> This is one of the fundamental plasma heating methods. A particle accelerator is used to create fast ion beams (the particle energies are on the order of 100 keV), the ion beam is then passed through a neutral gas region, where the ions neutralise via charge-exchange reactions with the neutral gas. The neutralised beam is then injected into a magnetically confined plasma. The neutral atoms are unaffected (not confined) by the magnetic field, but ionize as they penetrate into the plasma. The high-energy ions then transfer some of their energy to the plasma particles in repeated collisions, and heat the plasma.
(09 Oct 1997)
subcutaneous injection The delivery of a medication into the subcutaneous tissues via injection (for example insulin).
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á